TECH vs VERA · P/E 65, rev $1.22B vs $2.51B cap
Bio-Techne Corp (TECH) versus Vera Therapeutics Inc (VERA) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Vera Therapeutics Inc (VERA) is a biotechnology company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
VERA does not have a complete income-statement cache yet.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VERA currently screens at market cap $2.51B.
Not investment advice. Open the TECH and VERA stock pages for the full models.
Not investment advice.